Catherine Moukheibir's Insider Trades & SAST Disclosures
Catherine Moukheibir's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 24,311 Class A Common Stock done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Catherine Moukheibir.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,311 | 72,944 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Sale of securities on an exchange or to another person at price $ 6.36 per share. | 06 Jun 2024 | 44,426 | 84,207 (0%) | 0% | 6.4 | 282,549 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Sale of securities on an exchange or to another person at price $ 6.61 per share. | 06 Jun 2024 | 35,574 | 48,633 (0%) | 0% | 6.6 | 235,144 | Class A Common Stock |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,688 | 7,688 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 1,572 | 128,633 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 22,350 | 124,963 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 1,586 | 102,613 (0%) | 0% | 0 | Class A Common Stock | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 11,297 | 11,297 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 1,677 | 101,027 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,571 | 99,350 (0%) | 0% | 0 | Class A Common Stock | |
| MoonLake Immunotherapeutic... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 45,000 | 45,000 | - | - | Option to Buy | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 1,466 | 77,779 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 1,541 | 76,313 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 1,447 | 74,772 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 22,766 | 71,760 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 1,573 | 48,994 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | Catherine Moukheibir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 21,720 | 47,421 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges